Summary-
I. INTRODUCTION Low-frequency electromagnetic fields (LF-EMFs) have been suggested to contribute to the aetiology of neurodegenerative disorders [1, 2] . Recently, the correlation between LF-EMF exposure and its effects on the nervous system has been supported by occupational studies, which, in particular, have focused the attention on Alzheimer's disease (AD) [3] .
The mechanisms, by which an electromagnetic radiation can interact with the biological systems and cause neurodegenerative diseases, have been only partially investigated. At molecular level, it has been postulated that an electromagnetic wave can affect the redox status of the cells acting, in particular, on the formation of reactive oxygen species (ROS) and other free radicals, which could, in turn, damage lipids, proteins, carbohydrates, and nucleic acids present inside the cells [4] . Moreover, it has been reported that the response to LF-EMFs could evoke a general stress reaction [5] , in particular via the expression of the heat shock protein HSP70, whose transcriptional and translational levels increase during an electromagnetic stimulation in several cell lines and organisms.
Interestingly, it has been observed that, depending on the LF-EMF dose and on the cell type, the biological effects can induce cytotoxicity or cytoprotection [6] . The cytoprotection might be induced by a kind of "hormetic effect", in which low doses of otherwise adverse chemical/physical stimuli improve the "functional ability" of cells and tissues to face noxae. To this regard, based on the concept that the hormetic effect may implicate the strengthening of the molecular responses to stress, it has been proposed the use of a LF-EMF as a possible therapy against neurodegenerative disorders, such as AD, as documented by the delay of the cellular senescence associated with an increased expression of heat shock proteins [7] . Another hormetic action leading to biological improvements has been achieved in an in vivo study on a mouse model of AD, where the cognitive functions ameliorated as a consequence of a high-frequency EMF treatment [8] .
Taking into account all these considerations, our work was aimed to identify a possible beneficial action of LF-EMF on neuronal cells in aid of pathological conditions. To this purpose, we applied an electromagnetic stimulus (magnetic field intensity, 2 mT; frequency, 75 Hz) to SH-SY5Y human neuroblastoma cell line carrying an additional wild type copy of the amyloid precursor protein (APP 751 ) gene, and we studied the biological effects of this physical treatment: we mainly focused on the non-amyloidogenic APP pathway (i.e. the -secretase ADAM10 and the soluble neurotrophic factor sAPP).
II. MATERIALS AND METHODS

A. Cell cultures
The SH-SY5Y human neuroblastoma cell line was grown in Eagle's minimum essential medium (MEM) supplemented with 10% fetal calf serum, 1% penicillin-streptomycin, Lglutamine (2 mM), non-essential amino acids (1 mM), and sodium-pyruvate (1 mM) at 37°C in an atmosphere of 5% CO 2 and 95% humidity [9] . The SH-SY5Y cells, stably transfected with the vector of wild type APP isoform of 751 amino acids (APP 751 ) were prepared as previously described [9] .
B. Electromagnetic bioreactor and cell exposure
An electromagnetic bioreactor was built ( Fig. 1 ) [9] . It consisted of a carrying structure custom-machined in a tube of polymethylmethacrylate. The windowed tube carried two solenoids, the planes of whom were parallel. The cell cultures were 5 cm away from each solenoid plane and the solenoids were powered by a Biostim SPT pulse generator (Igea, Carpi, Italy), a generator of pulsed electromagnetic fields (PEMFs). In this experimental setup, the magnetic field and the induced electric field were perpendicular and parallel to the seeded cells, respectively.
Given the position of the solenoids and the characteristics of the pulse generator, the electromagnetic bioreactor applied to the cells a PEMF with the following characteristics: intensity of the magnetic field equal to 2 ± 0.2 mT, amplitude of the induced electric tension equal to 5 ± 1 mV, signal frequency of 75 ± 2 Hz, and pulse duration of about 1.3 ms. The electromagnetic bioreactor was placed into the cell culture incubator and the exposed cells were continuously stimulated by the PEMF for 72 hours (this duration is the maximum culture period without the need of medium change). The control cultures were placed into a different incubator in the absence of PEMF stimulation. 
C. Detection of the extracellular protein sAPP
The sAPP released in the medium was studied using a commercial ELISA kit and following the manufacturer's instructions (IBL International, Hamburg, Germany). Briefly, 100 l of diluted conditioned medium were added in wells pre-coated with monoclonal anti-human sAPP mouse IgG (clone 2B3). The samples were incubated overnight, washed, and then treated with HRP-conjugated anti-human APP mouse IgG (clone R101A4). The color reaction was performed using 3,3',5,5'-tetramethylbenzidine (TMB) substrate and the absorbance values were measured at 450 nm in a microplate reader (Bio-Rad Laboratories). All detections were performed in duplicate and the experiments were repeated at least three times. The results were expressed as ng/ml.
D. Statistics
The data were analyzed by the analysis of variance (ANOVA) followed by Tukey-Kramer test. Differences were considered statistically significant when p<0.05.
III. RESULTS
We focalized on ADAM10 protein since, due to its -secretase activity, it is involved in the non-amyloidogenic pathway of APP [9] .
The western blot analysis showed statistically significant increase in ADAM10 levels after 72 hours of electromagnetic stimulation (ADAM10/-tubulin ratio: 0.8804 ± 0.0409 [controls] vs. 1.1447 ± 0.0492 [exposed], two-tailed p<0.05, n=18÷20).
ADAM10 triggers the proteolysis of APP resulting in the formation of sAPP, which is a neurotrophic factor. For this reason, we investigated whether the release of the extracellular sAPP fragment may be altered by LF-EMF stimulation. Interestingly, a remarkable increase in the release of sAPP was noticed after 72 hours of stimulus: the comparison between the controls vs. the exposed cells confirmed the statistically significant increase of the sAPP secretion following LF-EMF exposure (59.2 ± 6.9 ng/ml [controls] vs. 90.6 ± 8.6 ng/ml [exposed], two-tailed p<0.01, n=16).
Taken together, these results indicated that the electromagnetic stimulation caused a rise in ADAM10 protein levels and a consequent release of the neurotrophic factor sAPP.
IV. DISCUSSION The present work was aimed to shed more light on the response of SH-SY5Y human neuroblastoma cells to a LF-EMF stimulus.
Of relevance, after 72 hours of electromagnetic stimulation, we detected an increase in the non-amyloidogenic processing of APP: as a matter of fact, we documented an enhanced expression of the -secretase ADAM10 associated with a higher release of the neurotrophic APP metabolite sAPP.
Collectively, our data indicated that the application of an appropriate LF-EMF, suitable in terms of both dose and timing, induced a kind of hormetic action resulting in some key cytoprotective responses: overexpression of HSP70 and SOD-1 (data not shown) and enhanced secretion of sAPP.
These effects may be of relevance under a Tissue Engineering viewpoint since they suggested a possible hormetic use of the LF-EMF stimulation in order to improve the functional ability of the neuronal cells to face noxae.
Concerning the neurodegenerative diseases, we could apply the physical parameters of this study to an Alzheimer's disease animal model such as that of Arendash et al. [8] , in order to evaluate the effects of a LF-EMF on an in vivo AD model.
In conclusion, our findings supported a cytoprotective action of the electromagnetic stimulation, although further studies are required to better understand the role of LF-EMF on neuronal cell responses such as proliferation, differentiation, apoptosis, and their underlying signaling pathways.
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